At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 97 enrolled
Drug / intervention
lorcaserin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
In Brief
A Phase 2 clinical trial evaluating lorcaserin, nicotine patch, and 1 other intervention for Nicotine Dependence. Completed, enrolled 97 participants across 1 site.
Detailed Summary
This study plans to compare the efficacy of the nicotine patch / lorcaserin combination treatment vs. the nicotine patch alone in terms of leading to a reduction in smoking behavior and withdrawal symptoms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNicotine Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartNov 2016
Primary CompletionMar 2018
Study CompletionOct 2018
TodayJul 2026
First PostedSep 20, 2016
Enrollment StartNov 8, 2016
Primary CompletionMar 27, 2018
Study CompletionOct 18, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.8 years ago
Interventions
lorcaserindrug
nicotine patchdrug
placebo lorcaserindrug